Pharmacia
This article was originally published in The Tan Sheet
Executive Summary
U.S. Rogaine sales jump 11% to $26 mil. in first quarter as hair regrowth treatment rebounds from private label competition, company says April 25. Nicorette revenues up 20% overall to $66 mil.; U.S. sales of Nicorette to GlaxoSmithKline and domestic sales of Nicotrol grow 5% to $19 mil. Consumer health segment nearly flat at $79 mil. in U.S., up 9% to $179 mil. overall. Total pharma sales increased 13% domestically and worldwide to $1.67 bil. and $3.21 bil., respectively